Centrient CEO Sees New Opportunities From Astral Acquisition

Rex Clements Sets Out Expectations For Integration Of Sterile Injectables Specialist

 
• By Dave Wallace

Acquiring Astral SteriTech will open up significant new capabilities in sterile injectables for Centrient while also offering an opportunity to expand the reach of the Indian firm’s products through Centrient’s infrastructure, CEO Rex Clements tells Generics Bulletin in an exclusive interview.

Businessman Bricks Puzzle Blocks Connect
Combining Centrient and Astral will open up new possibilities • Source: Alamy

More from Deals

More from Business